Corporate ActionOct 20, 2026, 04:11 PM
Tempest Therapeutics Adjourns Special Meeting on Charter Amendment Vote
AI Summary
Tempest Therapeutics, Inc. reconvened its special meeting of stockholders on October 14, 2026, to vote on a proposed amendment to its Restated Certificate of Incorporation. The amendment seeks to replace supermajority voting requirements and allow for stockholder action by written consent. Although a quorum was met, the proposal did not achieve the necessary 75% affirmative vote. Consequently, the meeting was adjourned and will reconvene on November 12, 2026, with no changes to the proposal or record date.
Key Highlights
- Tempest Therapeutics reconvened its special meeting of stockholders on October 14, 2026.
- The meeting's purpose is to approve an amendment to the Company's Restated Certificate of Incorporation.
- The amendment aims to replace supermajority voting requirements and permit stockholder action by written consent.
- A quorum of 74.3% of outstanding common stock was present, but the proposal did not receive sufficient votes.
- The Special Meeting has been adjourned and will reconvene on November 12, 2026, at 2:00 p.m. Eastern Time.
- The proposal requires at least a 75% affirmative vote from stockholders.
Price Impact
More from TPST